Yuri Matusov, MD, FACP, FCCP, ATSF

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    In-Kind Research Support
    Ineligible company:
    United Therapeutics
    Topic:
    Pulmonary Hypertension
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    In-Kind Research Support
    Ineligible company:
    Tenax
    Topic:
    Pulmonary Hypertension
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    In-Kind Research Support
    Ineligible company:
    Penumbra
    Topic:
    Pulmonary Embolism
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Mallinckrodt
    Topic:
    ARDS
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    In-Kind Research Support
    Ineligible company:
    Aerovate
    Topic:
    Pulmonary Hypertension
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
    Relationship end date:
    01/02/2025
  • Attribution:
    Self
    Type of financial relationship:
    In-Kind Research Support
    Ineligible company:
    BioAegis
    Topic:
    ARDS
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    United Therapeutics
    Topic:
    Pulmonary Hypertension
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Jupiter Endovascular
    Topic:
    Pulmonary Embolism
    Date added:
    09/25/2026
    Date updated:
    09/25/2026
Return to 1032_SCCM_SoCal Annual Symposium_Live